{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:21:46Z","timestamp":1793906506707,"version":"4.8.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.parkreldis.2009.07.014","type":"journal-article","created":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T06:44:48Z","timestamp":1251355488000},"page":"101-104","source":"Crossref","is-referenced-by-count":5,"title":["Autoimmune polyendocrine syndrome type I and brain calcinosis"],"prefix":"10.1016","volume":"16","author":[{"given":"Alon","family":"Abraham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Ziv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Steinmetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Groshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Djaldetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2009.07.014_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s001170050965","article-title":"Prevalence and clinical significance of computerized tomography verified idiopathic calcinosis of the basal ganglia","volume":"41","author":"Gomille","year":"2001","journal-title":"Radiologe"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib2","first-page":"507","article-title":"Basal ganglia calcification","volume":"47","author":"Sanchetee","year":"1999","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1399-0004.1985.tb02037.x","article-title":"Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED): autosomal recessive inheritance","volume":"27","author":"Ahonen","year":"1985","journal-title":"Clin Genet"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s004390050846","article-title":"A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients","volume":"103","author":"Rosatelli","year":"1998","journal-title":"Hum Genet"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00109-001-0306-2","article-title":"The genetic background of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and its autoimmune disease components","volume":"80","author":"Vogel","year":"2002","journal-title":"J Mol Med"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng1297-393","article-title":"Positional cloning of the APECED gene","volume":"17","author":"Nagamine","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/07853899708998786","article-title":"Cloning of the APECED gene provides new insight into human autoimmunity","volume":"31","author":"Aaltonen","year":"1999","journal-title":"Ann Med"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib8","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1056\/NEJMra030158","article-title":"Autoimmune polyendocrine syndromes","volume":"350","author":"Eisenbarth","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib9","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1212\/01.wnl.0000313837.45525.b6","article-title":"Neurologic consequences of autoimmune polyglandular syndrome type 1","volume":"70","author":"Berger","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-1781(03)00202-6","article-title":"Mineralization of the basal ganglia: implications for neuropsychiatry, pathology and neuroimaging","volume":"121","author":"Casanova","year":"2003","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib11","first-page":"55","article-title":"Mechanism of intracerebral calcification in hypoparathyroidism","volume":"14","author":"Fujita","year":"2004","journal-title":"Clin Calcium"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s004010051072","article-title":"Basal ganglia calcification induced by excitotoxicity: an experimental model characterised by electron microscopy and X-ray microanalysis","volume":"98","author":"Mahy","year":"1999","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0736-5748(99)00098-2","article-title":"Excitatory amino acids and neurodegeneration: a hypothetical role of calcium precipitation","volume":"18","author":"Rodr\u00edguez","year":"2000","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib14","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/mds.21438","article-title":"Neurological deficits are associated with increased brain calcinosis, hypoperfusion, and hypometabolism in idiopathic basal ganglia calcification","volume":"22","author":"Saiki","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1212\/WNL.26.3.221","article-title":"Calcifications of the basal ganglia as a cause of levodopa-resistant parkinsonism","volume":"26","author":"Klawans","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00314718","article-title":"Unsuccessful treatment with levodopa of a parkinsonian patient with calcification of the basal ganglia","volume":"218","author":"Berendes","year":"1978","journal-title":"J Neurol"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/mds.870080332","article-title":"Levodopa-responsive parkinsonism associated with basal ganglia calcification and primary hypoparathyroidism","volume":"8","author":"Vaamonde","year":"1993","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib18","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone (1\u201334) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib19","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/jnnp.71.5.691","article-title":"Regression of ventral striatum hypometabolism after calcium\/calcitriol therapy in paroxysmal kinesigenic choreoathetosis due to idiopathic primary hypoparathyroidism","volume":"71","author":"Volont\u00e9","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/mds.870130225","article-title":"Functional improvement in a patient with cerebral calcinosis using a bisphosphonate","volume":"13","author":"Loeb","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2009.07.014_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jns.2005.11.033","article-title":"Brain calcifications induce neurological dysfunction that can be reversed by a bone drug","volume":"243","author":"Loeb","year":"2006","journal-title":"J Neurol Sci"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802009002016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802009002016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T09:56:35Z","timestamp":1545040595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802009002016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S1353802009002016"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2009.07.014","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}